Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Zurita, Amado J.
Danziger, Natalie
Scott, Takara
Gjoerup, Ole
Zhong, Lei
Tukachinsky, Hanna
Ross, Jeffrey S.
Graf, Ryon
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] SUNY Upstate Med Univ, Syracuse, NY USA
[4] Fdn Med Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.455
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
455
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [41] Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
    Bidard, Francois-Clement
    Madic, Jordan
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rampanou, Aurore
    Servois, Vincent
    Cassoux, Nathalie
    Desjardins, Laurence
    Milder, Maud
    Vaucher, Isabelle
    Pierga, Jean-Yves
    Lebofsky, Ronald
    Stern, Marc-Henri
    Lantz, Olivier
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) : 1207 - 1213
  • [42] Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) - a validation study
    Pond, G. R.
    Dietrich, M.
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).
    Moudgil-Joshi, Jigi
    Stares, Mark
    Laird, Alex
    Leung, Steve
    Malik, Jahangeer
    Sundaramurthy, Aravindhan
    Symeonides, Stefan N.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [44] CLINICAL PROGNOSTIC FACTORS ASSOCIATED WITH OUTCOME IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH ANTIANGIOGENIC AGENTS
    Bracarda, S.
    De Angelis, V.
    Caserta, C.
    Rossi, M.
    Hamzaj, A.
    Crino, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 195 - 195
  • [45] Burden of cancer in metastatic renal cell carcinoma (mRCC).
    Battle, Dena
    Griffith, Meghan
    Msaouel, Pavlos
    Psutka, Sarah P.
    Vaishampayan, Ulka N.
    Zhang, Tian
    Staehler, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [46] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [47] Plasma circulating tumor DNA is scarce and confounded by clonal hematopoiesis in metastatic renal cell carcinoma
    Bacon, Jack V. W.
    Annala, Matti
    Soleimani, Maryam
    Lavoie, Jean-Michel
    So, Alan I.
    Gleave, Martin E.
    Fazli, Ladan
    Chi, Kim N.
    Kollmannsberger, Christian K.
    Wyatt, Alexander W.
    Nappi, Lucia
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 43 - 43
  • [48] Effect of nivolumab on tumor growth rate (TGR) in metastatic renal cell carcinoma (mRCC).
    Mazza, Camille
    Arfi-Rouche, Julia
    Koscielny, Serge
    Caramella, Caroline
    Lahmar, Jihene
    Escudier, Bernard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [49] Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC).
    Ivanyi, Philipp
    Eggers, Hendik
    Seidel, Christoph Alexander
    Reuter, Christoph
    Ganser, Arnold
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Prognostic Value of Residual Circulating Tumor DNA in Metastatic Pancreatic Ductal Adenocarcinoma
    Kim, Hongkyung
    Lee, Jinho
    Park, Mi Ri
    Choi, Zisun
    Han, Seung Jung
    Kim, Dongha
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    Park, Seung Woo
    ANNALS OF LABORATORY MEDICINE, 2025, 45 (02) : 199 - 208
12345